4//SEC Filing
Suzdak Peter David 4
Accession 0001140361-17-032420
CIK 0001228627other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:05 PM ET
Size
4.7 KB
Accession
0001140361-17-032420
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Common Stock
2017-08-16$1.99/sh+10,000$19,872→ 16,000 total
Footnotes (1)
- [F1]The price of $1.9872 per share represents a weighted average of purchase prices ranging from $1.96 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001296629
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:05 PM ET
- Size
- 4.7 KB